What is the standard of care for metastatic renal cell carcinoma: First-line, Second-line?
Dean F. Bajorin, MD • Supply participants recently identified risk categories and tumor biology of metastatic renal cell cancer; • Present a comprehensive understanding of the treatment paradigms available for initial treatment of renal cell carcinoma based on randomized trials; • Provide an overview of recent and ongoing trials evaluating therapy in patients whose disease has progressed despite initial treatment.
